Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open label study using the P. falciparum induced blood stage malaria (IBSM) model to determine the safety and tolerablity and to characterise the antimalarial activity of a single-dose oral administration of ZY-19489 in healthy adult volunteers

Next Previous
Search
Trial Profile

Open label study using the P. falciparum induced blood stage malaria (IBSM) model to determine the safety and tolerablity and to characterise the antimalarial activity of a single-dose oral administration of ZY-19489 in healthy adult volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 14 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ZY 19489 (Primary)
  • Indications Malaria
  • Focus Adverse reactions; First in man
  • Sponsors Cadila Healthcare

    • Most Recent Events

    • 01 Jun 2022 Results published in The Lancet Infectious Diseases
    • 04 Feb 2021 Results presented in a Zydus Cadila media release.
    • 04 Feb 2021 According to a Zydus Cadila media release, the company has completed this Phase 1 study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top